23,727 minors with comorbidities vaccinated vs COVID-19

A total of 23,727 minors aged 12 to 17 with comorbidities have been vaccinated against COVID-19.

The Department of Health (DOH) reported that among these vaccinated minors, 25 adverse events were recorded, with three classified as serious.

These serious adverse events included severe allergic reactions like anaphylaxis, with one or two cases requiring oxygen support and hospital admission.

Most cases involved mild allergies, injection site soreness, or anxiety-related responses to immunization.

Minors who required hospitalization were typically discharged within one to two days.

The government is set to start with the vaccination of the pediatric population with or without comorbidities on November 3, and full implementation is set to begin on November 5.

Nationwide, there are 12,722,070 individuals aged 12 to 17, with a target to vaccinate at least 80 percent of this population with two doses by December.